Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant (ASCENT)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03924401 |
|
Recruitment Status :
Recruiting
First Posted : April 23, 2019
Last Update Posted : April 6, 2023
|
Sponsor:
Emory University
Collaborators:
Thrasher Research Fund
Sickle Cell Transplant Advocacy & Research Alliance (STAR)
Aflac Cancer and Blood Disorders Center
Bristol-Myers Squibb
Information provided by (Responsible Party):
John Horan, Emory University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | March 2025 |
| Estimated Study Completion Date : | March 2025 |